UK-based biotechnology firm Biotica Technology and the University
of Cambridge have secured funding for a collaborative research
initiative into new expression systems for the production of
The rumours of a marriage between Japanese drugmakers Sankyo and
Daiichi Pharmaceutical were confirmed on Friday, when the two
companies officially announced their intention to merge in a stock
deal valued at around Y 813.0 billion...
Having opted to hang onto its pharmaceutical packaging business
instead of selling it off, Denmark's Superfos has now expanded the
production capacity of the unit 'to extend its position as one of
the leading suppliers in...
Pharmacogenomics will alter the balance of power in the way drugs
are developed, tested, marketed and prescribed during the next
decade, and the blockbuster business model of big pharmaceutical
companies will eventually give way to...
Researchers have found a protein, which plays a significant role in
colorectal carcinoma. The protein blocks the ability of tumours to
activate a natural self-destruct mechanism that would clear the
cancer from the body.
Nanotechnology for molecular targeting and drug delivery is set to
become a trillion-dollar industry, fuelled by the pharmaceutical
industry, which faces increasingly challenging market conditions.
This has lead to an intensified...
New statistics released today show that total US investments in
R&D made by the biotechnology and pharmaceutical industry
topped $38.8 billion (€29.3 billion) during 2004. This beats the
$34.5 billion total set in 2003 and demonstrates...
ITI Life Sciences and CXR Biosciences together with Artemis
Pharmaceuticals have entered into a £5.5 million (€7.9 million)
R&D programme to develop new screening and safety models to
more accurately predict the effects of drug...
Agilent Technologies has introduced the first high-performance
liquid chromatography (HPLC)-chip/mass spectrometry (MS) system for
protein identification. This breakthrough microfluidics-based LC/MS
technology is expected to significantly...
Worldwide demand for packaging equipment for the pharmaceutical and
personal care products sector is forecast to post the strongest
gains of any market through 2008, reaching $4.4 billion in that
Japanese company GSI Creos has unveiled the first prototype of a
new cell culture reactor that uses nanotechnology to support the
growth of more cells than conventional reactors. The bioreactor
could potentially boost the yield of...
BioPartners, currently leading the line amongst companies trying to
bring copies of off-patent biologic drugs to the European market,
has licensed a needle-free delivery technology for its human growth
hormone (hGH) product.